The Department of Pediatrics

Pediatric Specialty Center of Saint Barnabas

Department Physicians

Chayim Y. Newmark, M.D.

To request an appointment for Dr. Chayim Y. Newmark, please visit our Physician Search site.

Current Research

• Principal Investigator, A Phase 2/3, Randomized, Double-Blind, Multicenter, Multinational, 4-Arm, Controlled, Dose-Ranging Study to Evaluate Efficacy and Safety of MGA031, a Humanized, FcR Non-Binding, Anti-CD3 Monoclonal Antibody, in Children and Adults with Recent-Onset Type 1 Diabetes Mellitus (MGA031-01)
• Principal Investigator, A Phase III, Multicentre, Randomized, Parallel Group Study of Safety and Efficacy of the LB3002 A New Sustained Release Formulation of Human Recombinant Growth Hormone As compared to Standard Daily Therapy with Genotropin in Treatment Naïve Children with Growth Failure Due to Insufficient Secrection of Endogenous Growth Hormone (BPLG-004)
• Principal Investigator, A Four-Year Open-Label Multi-Center Randomized Two-Arm Study of Genotropin in Idiopathic Short Stature Patients: Comparing An Individualized, Target-Driven Treatment Regimen To Standard Dosing of Genotropin
• Principal Investigator, Recombinant human insulin-like growth factor-1 [rhIGF-1] treatment of prepubertal children with growth failure associated with primary IGF-1 deficiency:  A phase 3, randomized, open-label, observation-controlled, multicenter, parallel-dose comparison trial
• Principal Investigator, Increlex™ (mecasermin [rDNA origin] injection) Growth  Forum Database – IGFD Registry: A Patient Registry for Monitoring Long-term Safety and Efficacy of Increlex™
• Principal Investigator, Genentech National Cooperative Group Study (NCGS) Post Marketing Surveillance Program for Nutropin Aqa [Somatropin (rDNA Origin) Injection], Nutropin [Somatropin (rDNA Origin) for Injection], Nutropin Depot [Somatropin (rDNA Origin) for Injectable Suspension], and Protropin [Somatrem for Injection]
• Principal Investigator, The Genetics And Neuroendocrinology of Short Stature International Study (GeNeSIS) - Investigator
• Principal Investigator, The Answer Program™ - American Norditropin Studies: Web Enabled Research
• Principal Investigator, KIGS – Kabi International Growth Study Program
• Principal Investigator, GH Monitor – The Clinical Registry for Growth Hormone Therapy

Invited Lectures

• McCune Albright: Review and Treatment of Precocious Puberty. Washington University, 2004
• Cryptic Y chromosome Material in Girls with Turner Syndrome and Risk of Gonadoblastoma. Washington University, 2005
• Pediatric Endocrinology for the General Pediatrician, Saint Barnabas Medical Center, November 2006
• Update on Newborn Screening for Congenital Hypothyroidism and Congenital Adrenal Hyperplasia,  Saint Barnabas Medical Center, March 2007
• Update on Pediatrics Endocrinology Research, Clara Maas Medical Center, March 2008
• Timing and mechanism of estrogen replacement in Turner Syndrome, Turner Society Meeting, July 2009

Publications

• Newmark CY, White NH. Utilization of Postprandial Blood Glucose (BG) Determinations in Adolescents with Type 1 Diabetes (T1DM) Using Basal: Bolus Therapy Improves Glycemic Control. American Diabetes Association, Abstract 403-P, 2006.
• Newmark C, Lutzker L, Oppenheimer E, Anhalt H.  Radioiodine Ablation as Successful First Line Therapy - A Three Year, One Institution Experience, Abstract, 2008.

Invited Publications

• Newmark CY, Anhalt H. Type 2 Diabetes in Children and Adolescents. Pediatric Annals, 2007; 36(2):109-13
• Newmark CY, Anhalt H.  Controversies in Care in Pediatric Endocrinology: The Great Debate, The Endocrinologist. 2007; 17(3): 141-3  

Editorialship

• MD Net Guide – Pediatrics Edition; Editor-in-Chief;

 Journal Review Board

• Journal of Pediatric Endocrinology
• The Journal of the American Osteopathic Association

To request an appointment for Dr. Chayim Y. Newmark, please visit our Physician Search site.